CNSY · Cerenome Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 1.30 USD |
|---|---|
| 1-day change | -24.0% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 25 / 4 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 4 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -24.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +92.8% |
| Market cap (USD) | $26.4M |